[HTML][HTML] Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis

AER Kartikasari, CS Huertas, A Mitchell… - Frontiers in …, 2021 - frontiersin.org
Chronic inflammation generated by the tumor microenvironment is known to drive cancer
initiation, proliferation, progression, metastasis, and therapeutic resistance. The tumor …

Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer

MN Amin, SA Siddiqui, M Ibrahim… - SAGE open …, 2020 - journals.sagepub.com
Inflammatory cytokines are highly inducible small glycoproteins or regulatory proteins of low
molecular weight secreted by different cell types. They regulate intercellular communication …

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

DC Wedge, G Gundem, T Mitchell, DJ Woodcock… - Nature …, 2018 - nature.com
Prostate cancer represents a substantial clinical challenge because it is difficult to predict
outcome and advanced disease is often fatal. We sequenced the whole genomes of 112 …

Androgen receptor signaling in prostate cancer

Z Culig, FR Santer - Cancer and Metastasis Reviews, 2014 - Springer
The androgen receptor (AR), ligand-induced transcription factor, is expressed in primary
prostate cancer and in metastases. AR regulates multiple cellular events, proliferation …

[HTML][HTML] Androgen receptor signaling in prostate cancer development and progression

PE Lonergan, DJ Tindall - Journal of carcinogenesis, 2011 - ncbi.nlm.nih.gov
The androgen receptor (AR) signaling axis plays a critical role in the development, function
and homeostasis of the prostate. The classical action of AR is to regulate gene …

[PDF][PDF] MicroRNA‐26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin‐6‐Stat3 pathway

X Yang, L Liang, XF Zhang, HL Jia, Y Qin, XC Zhu… - …, 2013 - Wiley Online Library
Down‐regulation of microRNA‐26a (miR‐26a) is associated with poor prognosis of
hepatocellular carcinoma (HCC), but its functional mechanism in HCC remains unclear. In …

The mutational landscape of prostate cancer

CE Barbieri, CH Bangma, A Bjartell, JWF Catto, Z Culig… - European urology, 2013 - Elsevier
Abstract Context Prostate cancer (PCa) is a clinically heterogeneous disease with marked
variability in patient outcomes. Molecular characterization has revealed striking mutational …

How the association between obesity and inflammation may lead to insulin resistance and cancer

MN Amin, MS Hussain, MS Sarwar… - Diabetes & Metabolic …, 2019 - Elsevier
Background and objectives Obesity is associated with metabolic dysfunction and over
nutrition. Increased body mass index and obesity are strongly amalgamated with changes in …

[HTML][HTML] Androgen deprivation of prostate cancer: Leading to a therapeutic dead end

A Katzenwadel, P Wolf - Cancer letters, 2015 - Elsevier
Androgen deprivation therapy (ADT) is considered as the standard therapy for men with de
novo or recurrent metastatic prostate cancer. ADT commonly leads to initial biochemical and …

Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop

P Yang, L Guo, ZJ Duan, CG Tepper… - … and cellular biology, 2012 - Taylor & Francis
Constitutive NF-κB activation by proinflammatory cytokines plays a major role in cancer
progression. However, the underlying mechanism is still unclear. We report here that histone …